90R2679 MEW-F By: Gervin-Hawkins H.B. No. 1153 A BILL TO BE ENTITLED AN ACT relating to coverage for screening mammograms, diagnostic imaging, and supplemental breast examinations under certain health benefit plans. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 1356.001, Insurance Code, is amended by amending Subdivision (1-a) and adding Subdivisions (1-b) and (3) to read as follows: (1-a) Added text: "Cost-sharing requirement" means a deductible, coinsurance, or copayment or a maximum limitation on the application of a deductible, coinsurance, or copayment or similar out-of-pocket expense. (End of added text) Added text: (1-b) (End of added text) "Diagnostic imaging" means Added text: a medically necessary and appropriate (End of added text)Deleted text: an imaging (End of deleted text)examination Added text: of the breast, as determined by National Comprehensive Cancer Network guidelines, including an examination (End of added text) using Added text: contrast-enhanced (End of added text) mammography, Added text: diagnostic mammography, breast (End of added text) ultrasound imaging, Added text: breast (End of added text)Deleted text: or (End of deleted text)magnetic resonance imagingAdded text: , or molecular breast imaging, (End of added text) that is designed to evaluate: (A) a subjective or objective abnormality detected by a physician or patient in a breast; (B) an abnormality seen by a physician on a screening mammogram; (C) an abnormality previously identified by a physician as probably benign in a breast for which follow-up imaging is recommended by a physician; or (D) an individual with a personal history of breast cancer or dense breast tissue. Added text: (3) "Supplemental breast examination" means a medically necessary and appropriate examination of the breast, as determined by National Comprehensive Cancer Network guidelines, including an examination using contrast-enhanced mammography, breast ultrasound imaging, breast magnetic resonance imaging, or molecular breast imaging, that is: (End of added text) Added text: (A) used to screen for breast cancer when an abnormality has not been seen or suspected by a physician; and (End of added text) Added text: (B) based on a patient's personal or family medical history or other factors that increase the patient's risk of breast cancer, including heterogeneously or extremely dense breasts. (End of added text) SECTION 2. Section 1356.005(b), Insurance Code, is amended to read as follows: (b) Added text: A health benefit plan may not impose a cost-sharing requirement on coverage for a screening mammogram, diagnostic imaging, or supplemental breast examination (End of added text)Deleted text: Coverage required by this section: (End of deleted text)Deleted text: (1) may not be less favorable than coverage for other radiological examinations under the plan; and (End of deleted text)Deleted text: (2) must be subject to the same dollar limits, deductibles, and coinsurance factors as coverage for other radiological examinations under the plan (End of deleted text). SECTION 3. If before implementing any provision of this Act a state agency determines that a waiver or authorization from a federal agency is necessary for implementation of that provision, the agency affected by the provision shall request the waiver or authorization and may delay implementing that provision until the waiver or authorization is granted. SECTION 4. This Act applies only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2028. A health benefit plan that is delivered, issued for delivery, or renewed before January 1, 2028, is governed by the law as it existed immediately before the effective date of this Act, and that law is continued in effect for that purpose. SECTION 5. This Act takes effect September 1, 2027.
← Back to HB 1153
HB 1153 · Version I
Introduced
Dated Nov 13, 2026
Underlined: added by this bill. Struck through: removed by this bill. Plain words stay as they are.